Growth Metrics

OptimizeRx (OPRX) Cash from Operations (2016 - 2026)

OptimizeRx's Cash from Operations history spans 16 years, with the latest figure at 7088000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 3479.8% to 7088000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 18715000.0, a 282.8% increase, with the full-year FY2025 number at 18715000.0, up 282.8% from a year prior.
  • Cash from Operations hit 7088000.0 in Q4 2025 for OptimizeRx, up from 3202000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for OPRX hit a ceiling of 7088000.0 in Q4 2025 and a floor of 6258000.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 1387205.85 across 5 years, with a median of 1569375.0 in 2021.
  • Biggest five-year swings in Cash from Operations: tumbled 868.84% in 2023 and later skyrocketed 3479.8% in 2025.
  • Tracing OPRX's Cash from Operations over 5 years: stood at 1334543.0 in 2021, then surged by 310.07% to 2803484.0 in 2022, then tumbled by 323.22% to 6258000.0 in 2023, then surged by 103.16% to 198000.0 in 2024, then skyrocketed by 3479.8% to 7088000.0 in 2025.
  • Business Quant data shows Cash from Operations for OPRX at 7088000.0 in Q4 2025, 3202000.0 in Q3 2025, and 4561000.0 in Q2 2025.